Tourmaline Bio's market cap is currently $1.23B. The company's EPS TTM is $-0.9; its P/E ratio is ―; Tourmaline Bio is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
